ArriVent BioPharma, Inc. Common Stock Net Asset Quality Index
ArriVent BioPharma, Inc. Common Stock net asset quality index. ArriVent BioPharma, Inc. Common Stock (AVBP) has a Net Asset Quality Index of 92.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $394.72 Million minus total liabilities of $27.88 Million yields net assets of $366.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. See ArriVent BioPharma, Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ArriVent BioPharma, Inc. Common Stock (2021–2025)
Net asset quality index of ArriVent BioPharma, Inc. Common Stock from 2021 to 2025. This chart shows how ArriVent BioPharma, Inc. Common Stock's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 92.9%, representing net assets of $366.84 Million against total assets of $394.72 Million USD. Check AVBP strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
ArriVent BioPharma, Inc. Common Stock Net Asset Quality Index by Year (2021–2025)
ArriVent BioPharma, Inc. Common Stock net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for ArriVent BioPharma, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AVBP market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.2% | $307.22 Million | $333.17 Million | $25.95 Million | ▼ -1.5 pp |
| 2024 | 93.7% | $257.65 Million | $274.94 Million | $17.29 Million | ▲ +0.9 pp |
| 2023 | 92.8% | $151.30 Million | $163.10 Million | $11.80 Million | ▼ -2.7 pp |
| 2022 | 95.4% | $174.46 Million | $182.83 Million | $8.37 Million | ▼ -0.4 pp |
| 2021 | 95.8% | $41.22 Million | $43.04 Million | $1.82 Million | — |